American International Group, Inc. Compass Therapeutics, Inc. Transaction History

American International Group, Inc.

  • $8.86 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$1.2 - $2.29 $463 - $883
-386 Reduced 0.85%
44,974 $89,000
Q4 2023

Feb 13, 2024
SELL
$1.4 - $1.98 $257 - $364
-184 Reduced 0.4%
45,360 $70,000
Q3 2023

Nov 13, 2023
BUY
$1.87 - $3.25 $3,029 - $5,265
1,620 Added 3.69%
45,544 $89,000
Q2 2023

Aug 04, 2023
BUY
$2.64 - $3.48 $115,959 - $152,855
43,924 New
43,924 $139,000

Others Institutions Holding CMPX

# of Institutions
82
Shares Held
92.8M
Call Options Held
0
Put Options Held
0
View Full List

About Compass Therapeutics, Inc.

CMPX Quotes by TradingView
  • Ticker CMPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 101,285,000
  • Market Cap $186M
  • Description
  • Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...
More about CMPX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email